峰鉴别3用罗匹尼罗

C₁₆H₂₄N₂O · HCl

296.84

MFCD01754173

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

An agonist at the D₂ and D₃ dopamine receptor subtypes, binding with higher affinity to D₃ than to D₂ or D₄. It has negligible effect on D₁-receptors. It has medium in vitro affinity to opioid receptors. Ropinirole is said to have virtually no affinity to 5-HT₁, 5-HT₂, benzodiazepine, GABA, muscarinic, α1-, α2-, and β-adrenoreceptors. Used as antiparkinsonian drug.

Sales restrictions may apply.

pharmaceutical primary standard

EDQM

neat

2-8℃

Cl.CCCN(CCC)CCc1cccc2NC(=O)Cc12

1S/C16H24N2O.ClH/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15;/h5-7H,3-4,8-12H2,1-2H3,(H,17,19);1H

XDXHAEQXIBQUEZ-UHFFFAOYSA-N

human ... DRD2(1813), DRD3(1814), DRD4(1815)

Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

GHS07,GHS09

Warning

H302 - H400

P264 - P270 - P273 - P301 + P312 + P330 - P391 - P501

Acute Tox. 4 Oral - Aquatic Acute 1

13 - Non Combustible Solids

WGK 3